No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
172 |
4. Check minimum number of eventsNone |
172 |
5. Include endpointsNone |
172 |
6. Filter based on genotype QC (FinnGen only) |
172 |
Control definitions (FinnGen only)
- Control exclude
- ASTHMA_COMORB
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J39
- Name in latin
- Alii morbi tractus respiratorii superioris specificati
Similar endpoints
↥List of similar endpoints to
Tracheo-bronchomalasia
based on the number of shared cases.
Similar with more cases:
- Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified
- Other diseases of upper respiratory tract
- Other pulmonary diagnosis
- Excluding asthma or asthma-COPD overlap
- COPD differential diagnosis
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 959 | 617 | 340 |
| Only index persons | 905 | 596 | 309 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 49.42 | 48.58 | 51.04 |
| Only index persons | 49.18 | 48.54 | 50.40 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 172 | 122 | 50 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | 52.74 | 51.04 | 56.87 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 157
- Matched controls
- 1569
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J39.8
ICD-10 Finland
Other specified diseases of upper respiratory tract
+∞
224.8
157
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
127.9
90.4
92
17
XG474
NOMESCO Finland
Exhalation nntrogen oxide
83.6
50.6
55
10
J45.9
ICD-10 Finland
Asthma, unspecified
13.7
37.1
71
89
R03AC02
ATC
salbutamol; inhalant
9.2
31.9
130
538
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
46.1
29.9
36
10
R03AK08
ATC
formoterol and beclometasone; inhalant
51.6
28.1
33
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.3
23.8
81
227
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
22.8
20.9
30
16
J39.9
ICD-10 Finland
Disease of upper respiratory tract, unspecified
56.2
20.8
24
5
R03BA08
ATC
ciclesonide; inhalant
10.7
20.4
41
50
A02BC02
ATC
pantoprazole; systemic
5.4
20.2
120
592
XQ800
NOMESCO Finland
Prick test
10.3
19.9
41
52
H02AB06
ATC
prednisolone; systemic
4.6
18.0
89
347
J45.1
ICD-10 Finland
Nonallergic asthma
13.0
16.9
30
28
R06.0
ICD-10 Finland
Dyspnoea
5.9
16.7
52
121
R05
ICD-10 Finland
Cough
5.6
16.6
55
138
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
7.9
15.9
38
61
A02BC05
ATC
esomeprazole; systemic
4.2
15.8
83
329
G47.3
ICD-10 Finland
Sleep apnoea
6.5
15.4
43
86
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.6
15.4
50
121
R01AD12
ATC
fluticasone furoate; nasal
4.0
14.9
82
334
215
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
14.8
14
*
103
Kela drug reimbursment
Diabetes, insulin-treated
+∞
14.8
14
*
R49.01
ICD-10 Finland
Functional dysphonia
15.5
14.8
24
18
I25.1
ICD-10 Finland
Atherosclerotic heart disease
58.9
14.1
16
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
16.8
14.1
22
15
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
28.8
13.7
18
7
C07AB07
ATC
bisoprolol; oral
4.3
13.5
60
199
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.0
13.3
47
123
R03DC03
ATC
montelukast; oral
4.9
13.1
47
125
I48
ICD-10 Finland
Atrial fibrillation and flutter
76.2
12.8
14
*
R03BA05
ATC
fluticasone; inhalant
4.6
12.1
46
129
SPAT1249
SPAT
Treatment-related counselling outside office
3.5
12.1
78
345
R5140
NOMESCO Finland
Monitoring the use of the aid
10.9
11.7
22
23
J38.3
ICD-10 Finland
Other diseases of vocal cords
+∞
11.6
11
*
R03BB04
ATC
tiotropium bromide; inhalant
9.4
11.3
23
28
SPAT1262
SPAT
Handing over of treatment supplies
8.1
11.1
25
36
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
30.5
10.9
14
5
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
23.5
10.9
15
7
WX780
NOMESCO Finland
Remote monitoring CPAP
23.5
10.9
15
7
N03AX12
ATC
gabapentin; oral
5.7
10.9
32
67
Z01.8
ICD-10 Finland
Other specified special examinations
4.2
10.9
45
136
T90
ICPC
Diabetes non-insulin dependent
15.7
10.8
17
12
207
Kela drug reimbursment
Chronic arrhythmias
+∞
10.5
10
*
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
43.1
10.1
12
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
7.3
10.0
24
38
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
28.1
10.0
13
5
ZXE00
NOMESCO Finland
One hour or less
3.1
10.0
75
357
N03AX16
ATC
pregabalin; oral
4.1
9.9
42
129
XX3DW
NOMESCO Finland
Time consuming IT work
5.5
9.9
30
65
A02BC03
ATC
lansoprazole; oral
3.7
9.8
49
173
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
8.2
9.6
21
29
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
106.2
9.5
10
*
R03BA01
ATC
beclometasone; inhalant
4.4
9.5
36
99
J45
ICD-10 Finland
Asthma
5.5
9.5
28
59
A10BA02
ATC
metformin; oral
14.9
9.4
15
11
E66.01
ICD-10 Finland
Obesity due to excess calories
14.9
9.4
15
11
R01AD08
ATC
fluticasone; nasal
3.1
9.4
66
297
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
13.7
9.1
15
12
A02BC01
ATC
omeprazole; systemic
3.5
9.0
47
169
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
3.3
9.0
54
217
WX723
NOMESCO Finland
CPAP therapy
15.2
8.9
14
10
UJF32
NOMESCO Finland
Coloscopy
3.8
8.9
41
135
R06AE07
ATC
cetirizine; oral
2.8
8.8
82
440
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.3
8.8
50
193
N02AJ06
ATC
codeine and paracetamol; systemic
2.9
8.7
68
326
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.9
8.7
71
350
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
94.9
8.5
9
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
94.9
8.5
9
*
SPAT1301
SPAT
No procedures
3.1
8.5
53
219
WZC30
NOMESCO Finland
Teaching
4.6
8.5
30
77
M01AE02
ATC
naproxen; oral, rectal
2.8
8.5
105
660
J38.7
ICD-10 Finland
Other diseases of larynx
+∞
8.4
8
*
N02AX02
ATC
tramadol; systemic, rectal
2.8
8.2
65
312
J01AA02
ATC
doxycycline; systemic
3.2
8.1
130
948
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
14.0
8.0
13
10
R23
ICPC
Voice symptom/complaint
14.0
8.0
13
10
F32.9
ICD-10 Finland
Depressive episode, unspecified
7.1
8.0
19
30
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.9
7.9
33
99
N06AX16
ATC
venlafaxine; oral
5.0
7.9
25
57
R06.5
ICD-10 Finland
Mouth breathing
16.1
7.8
12
8
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
47.4
7.8
9
*
R06AE09
ATC
levocetirizine; oral
3.6
7.8
37
124
H25.1
ICD-10 Finland
Senile nuclear cataract
26.5
7.7
10
*
UDC00
NOMESCO Finland
Ear microscopy
5.7
7.6
21
41
J01DB01
ATC
cefalexin; oral
3.2
7.3
135
1032
R03BA02
ATC
budesonide; inhalant
3.5
7.2
35
119
R06.2
ICD-10 Finland
Wheezing
9.5
7.2
14
16
J37.0
ICD-10 Finland
Chronic laryngitis
12.9
7.2
12
10
N02BE01
ATC
paracetamol; systemic, rectal
3.1
7.2
134
1020
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.2
7.1
27
74
SPAT1263
SPAT
Sampling
2.6
7.1
67
350
H03AA01
ATC
levothyroxine sodium; systemic
3.1
7.1
42
164
N06AX11
ATC
mirtazapine; oral
2.9
7.1
48
206
F51.0
ICD-10 Finland
Nonorganic insomnia
3.7
7.0
31
98
R42
ICD-10 Finland
Dizziness and giddiness
3.4
6.9
34
117
UKC02
NOMESCO Finland
Cystoscopy
4.6
6.9
23
56
J01DA01
ATC
[U] cefalexin; systemic
2.5
6.8
105
704
HMAK
NOMESCO Finland
NA
3.5
6.8
32
106
J01FA10
ATC
azithromycin; systemic
2.5
6.8
108
735
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.5
6.8
19
38
R49.09
ICD-10 Finland
Unspecified dysphonia
23.7
6.8
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
6.7
63
324
J02AC01
ATC
fluconazole; systemic
2.4
6.7
80
468
N06AA09
ATC
amitriptyline; systemic
5.2
6.7
20
43
N05BA04
ATC
oxazepam; oral
3.3
6.7
34
120
WX402
NOMESCO Finland
General anaesthesia
3.4
6.6
33
115
SCA03
NOMESCO Finland
Preventive oral health care, extensive
6.5
6.5
16
27
M01AE03
ATC
ketoprofen; systemic, rectal
2.5
6.5
60
307
R01AD01
ATC
beclometasone; nasal
3.2
6.5
36
135
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.8
6.4
47
209
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
11.7
6.4
11
10
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
7.6
6.4
14
20
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.8
6.3
15
24
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.4
6.3
22
56
A10BH01
ATC
sitagliptin; oral
+∞
6.3
6
*
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
6.3
6
*
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
+∞
6.3
6
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
+∞
6.3
6
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
+∞
6.3
6
*
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
+∞
6.3
6
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.3
6.2
83
508
SPAT1312
SPAT
General health counselling
2.5
6.2
57
289
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.0
6.2
16
29
B01AA03
ATC
warfarin; systemic
6.5
6.2
15
25
A02BA02
ATC
ranitidine; systemic
3.5
6.1
28
91
R03AK07
ATC
formoterol and budesonide; inhalant
2.9
6.1
40
165
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
6.3
6.0
15
26
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
54
65
11.65
44.17
3.0
2.7
mmol/l
1.2
1.2
0.40
48
53
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
11
30.21
40.70
2.1
3.5
e9/l
3.7
4.2
0.44
28
11
(40760892) CBC W Ordered Manual Differential panel - Blood
101
275
7.47
39.58
4.7
2.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
12
27.68
39.44
2.1
3.6
%
56.1
54.1
0.17
28
12
(40761536) Microorganisms panel - Urine sediment
57
99
8.12
34.06
4.0
3.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
95
279
6.37
33.24
4.5
4.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
47
87
7.06
25.98
2.4
2.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
60
143
5.91
25.55
1.8
1.4
pmol/l
405.4
440.2
0.50
44
129
(3032080) INR in Blood by Coagulation assay
81
258
5.04
24.42
9.8
2.8
inr
1.1
1.0
1.58
64
77
(3029937) Albumin [Presence] in Urine by Test strip
85
291
4.80
23.19
4.0
2.7
estimate
0.0
0.0
0.50
54
111
(3013290) Carbon dioxide [Partial pressure] in Blood
18
10
19.99
22.40
3.0
3.5
kpa
4.9
4.8
—
18
10
(3027315) Oxygen [Partial pressure] in Blood
18
10
19.99
22.40
3.0
3.5
kpa
8.6
10.4
—
18
10
(3021440) Promyelocytes/100 leukocytes in Blood
37
62
7.33
22.28
4.4
3.1
%
0.4
0.0
—
7
14
(3025159) Blasts/100 leukocytes in Blood
37
62
7.33
22.28
4.2
3.1
%
0.3
0.0
—
7
13
(3000492) Spirometry study
51
122
5.52
21.30
1.5
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
37
65
6.98
21.27
4.4
3.0
%
1.1
0.6
—
7
17
(3013512) EKG study
73
236
4.64
21.13
3.4
2.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
36
63
6.96
20.75
3.3
2.9
%
1.8
0.2
—
5
12
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
79
275
4.46
20.67
3.8
1.7
ng/l
12.5
24.3
0.91
44
117
(3013707) Erythrocyte sedimentation rate by Westergren method
150
849
6.99
20.26
5.0
2.5
mm/h
9.0
8.5
0.18
145
791
(3022096) Basophils/100 leukocytes in Blood
103
442
4.32
20.06
5.3
4.2
%
0.7
0.7
0.13
98
412
(3001604) Monocytes [#/volume] in Blood
108
490
4.24
19.20
5.5
4.2
e9/l
0.5
0.5
0.74
103
428
(3006504) Eosinophils/100 leukocytes in Blood
103
466
4.02
18.07
5.5
4.1
%
2.6
3.1
1.37
98
432
(3013826) Glucose [Moles/volume] in Serum or Plasma
108
506
4.05
17.97
2.8
3.0
mmol/l
6.1
6.0
0.55
102
461
(3018418) pH of Serum or Plasma
65
223
4.08
16.84
3.0
3.1
ph
7.4
7.4
0.16
42
43
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
69
258
3.80
15.62
2.4
1.9
u/l
54.2
62.9
0.84
60
233
(1616796) Gas panel - Central venous blood
14
10
15.15
15.22
2.3
3.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
96
457
3.49
14.74
4.3
2.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
81
348
3.51
14.65
4.0
2.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
105
533
3.49
14.44
3.4
2.4
ug/l
83.2
87.2
0.16
97
509
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
17
10.27
13.65
1.7
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
22
36
6.86
13.29
3.5
9.8
mmol/l
24.2
24.6
0.22
22
36
(3026493) Urate [Moles/volume] in Serum or Plasma
60
226
3.54
13.13
2.0
2.1
umol/l
302.1
9708.9
1.54
54
212
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
77
341
3.28
12.94
3.7
4.2
mmol/l
1.2
1.2
0.97
67
309
(3024561) Albumin [Mass/volume] in Serum or Plasma
73
314
3.30
12.86
3.4
4.0
g/l
36.4
37.1
0.65
65
291
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
131
800
3.67
12.66
6.9
5.2
u/l
69.0
75.1
1.36
124
746
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
93
468
3.15
12.43
4.2
5.5
umol/l
8.8
11.8
3.04
86
449
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
10
12.82
11.86
2.3
3.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
82
395
3.06
11.66
4.6
4.8
mmol/l
1.2
1.2
0.04
44
328
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
144
959
4.08
11.63
5.3
3.3
pmol/l
15.1
14.4
2.97
135
887
(40768797) Stomach Pathology biopsy report
37
109
4.05
11.47
1.4
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
80
387
3.00
11.20
2.4
1.8
nmol/l
80.0
77.4
0.33
71
359
(3021601) Nitrite [Presence] in Urine by Test strip
103
572
3.00
11.18
5.8
3.3
estimate
0.0
0.0
0.00
57
111
(3009261) Glucose [Presence] in Urine by Test strip
103
576
2.96
10.97
4.6
2.4
estimate
0.0
0.0
0.00
56
112
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
15
20
8.12
10.73
2.3
1.1
g/l
1.2
1.2
0.02
15
20
(3035350) Ketones [Presence] in Urine by Test strip
101
565
2.91
10.65
4.7
2.4
estimate
0.0
0.0
0.00
56
108
(3019309) Folate [Moles/volume] in Red Blood Cells
35
105
3.93
10.54
1.9
1.4
nmol/l
1566.4
1124.0
1.62
26
78
(1761868) Lipid panel - Serum or Plasma
102
577
2.89
10.48
2.9
2.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
8
20.36
10.46
2.5
2.4
—
—
—
0
0
(44813793)
15
8
20.36
10.46
1.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
14
6
25.21
10.42
1.5
1.3
mmol/l
2.1
1.2
—
14
6
(3044889) 12 lead EKG panel
123
772
3.08
10.35
4.2
2.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
48
182
3.27
10.12
2.5
1.5
mg/l
3.0
2.6
0.84
43
145
(3013650) Neutrophils [#/volume] in Blood by Automated count
105
611
2.84
10.09
7.6
7.4
e9/l
3.7
3.7
0.01
100
529
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
41
144
3.43
9.74
2.8
1.6
ng/l
564.9
390.0
0.38
31
120
(3022806) Fractional oxyhemoglobin in Capillary blood
13
6
23.27
9.50
1.5
1.2
%
91.5
91.6
—
13
6
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
155
1159
4.41
8.93
5.9
3.7
mu/l
1.7
2.8
0.55
144
1077
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
66
321
2.71
8.73
3.4
2.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
54
244
2.77
8.17
1.4
1.2
u/ml
1.1
1.2
0.02
31
68
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
210
2.78
7.68
1.3
1.1
u/ml
1.8
6.2
0.63
31
85
(3048689) Calprotectin [Mass/mass] in Stool
30
102
3.35
7.40
2.8
1.2
ug/g
106.0
39.2
0.68
21
78
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
16
7.28
7.24
1.9
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
31
5.21
7.07
1.4
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
36
146
2.85
6.56
2.6
1.9
mg/l
40.2
741.0
0.58
22
71
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
49
236
2.51
6.36
2.0
1.6
mg/l
0.5
0.6
0.72
33
184
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
121
859
2.38
6.30
3.2
2.2
u/l
36.5
33.9
0.34
111
823
(3015736) pH of Urine
72
413
2.28
6.29
4.0
2.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
153
1217
3.33
6.25
13.6
6.2
ml/min/173m2
84.8
86.7
0.73
143
965
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
165
1423
4.92
6.23
9.9
6.2
u/l
25.3
24.8
0.15
160
1375
(3022145) Colonoscopy Study observation
29
107
3.06
6.23
1.6
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
27
96
3.15
6.17
2.1
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
159
1297
3.99
6.16
15.6
6.9
mg/l
13.6
21.4
2.78
141
889
(3020682) Albumin/Creatinine [Ratio] in Urine
37
158
2.71
6.10
3.7
2.3
mg/mmol
4.8
16.0
1.48
21
82
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
16
6.57
6.02
1.1
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
13
28
4.94
5.84
1.4
3.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
39
176
2.57
5.75
2.7
1.9
mmol/l
8.6
7.9
0.31
31
153
(3044290) Cell count panel - Cerebral spinal fluid
10
17
6.18
5.69
1.1
2.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
7
13.47
5.64
1.0
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
29
4.77
5.61
1.5
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
144
1131
2.68
5.60
4.9
2.7
mmol/mol
38.2
36.2
3.28
129
1067
(3007164) IgA [Mass/volume] in Serum or Plasma
44
213
2.43
5.59
1.3
1.3
g/l
2.3
2.2
0.14
37
138
(3037467) Urinalysis macro (dipstick) panel - Urine
111
785
2.17
5.48
4.7
3.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
5
16.67
5.46
1.0
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
164
1438
4.02
5.16
14.7
6.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
27
4.70
5.12
1.4
2.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
9
10.47
5.09
1.8
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
28
4.53
4.91
4.0
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
43
218
2.30
4.87
1.3
1.1
iu/ml
9.4
18.9
0.78
16
63
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
11
8.56
4.62
1.8
1.6
mmol/l
24.3
24.8
—
9
11
(3012565) Volume of 24 hour Urine
7
5
14.50
4.61
2.4
1.6
ml
2007.9
1850.0
—
7
5
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
8
10.41
4.57
3.1
1.3
pg
32.3
32.0
—
8
8
(3031040) Bacteria [#/volume] in Urine by Automated count
101
720
1.98
4.52
4.8
3.2
—
29.2
—
0
6
(36304419) Bacteria [Presence] in Urine
45
241
2.17
4.44
3.4
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
50
280
2.11
4.40
1.5
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
48
265
2.13
4.38
3.6
2.4
e6/l
36.2
85.2
0.37
42
197
(4062490)
7
6
12.08
4.31
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
35
171
2.31
4.29
1.3
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
55
323
2.03
4.25
4.3
2.8
e6/l
10.0
41.3
1.20
48
209
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
26
111
2.58
4.25
2.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
78
523
1.90
4.07
1.7
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
149
1248
2.45
4.04
4.5
2.9
mmol/l
5.7
5.4
3.25
137
1173
(3025941) Bacteria identified in Stool by Culture
17
60
3.03
3.92
1.3
1.3
—
—
—
0
0
(4035726)
25
109
2.51
3.91
1.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
23
97
2.58
3.85
2.3
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
193
0.24
3.69
1.4
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
6
10.30
3.52
1.7
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
18
5.21
3.42
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
7
8.82
3.29
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
11
6.58
3.21
1.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
31
163
2.10
3.16
1.6
1.2
nmol/l
22.7
21.3
0.16
26
135
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
34
3.39
3.11
1.2
1.1
u/ml
1.2
1.3
—
5
12
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
16
5.19
3.09
1.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
8
7.72
3.08
1.5
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
8
7.72
3.08
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
8
7.72
3.08
1.2
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
17
4.88
2.95
1.5
3.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
17
4.88
2.95
1.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
9
6.86
2.89
1.2
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
6
8.53
2.76
1.4
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
37
3.11
2.74
1.5
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
10
6.17
2.72
1.0
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
30
166
1.98
2.66
5.5
3.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
15
4.82
2.62
1.6
3.3
g/l
12.4
10.4
—
7
15
(40761535) Cells panel - Urine sediment
14
57
2.59
2.52
3.6
2.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
16
71
2.38
2.43
2.5
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
12
5.14
2.42
1.2
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
8
6.39
2.38
1.6
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
149
1321
1.96
2.37
4.3
3.2
mmol/l
1.6
1.6
0.19
136
1256
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
13
4.74
2.29
4.2
1.2
mmol/l
25.7
26.7
—
6
13
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
6
13
4.74
2.29
5.5
1.7
%
51.4
33.1
—
6
13
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
47
314
1.68
2.27
1.9
1.3
pmol/l
84.2
101.1
1.27
20
169
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
149
1327
1.92
2.24
4.3
3.2
mmol/l
4.7
5.0
3.49
135
1259
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
19
3.79
2.17
1.0
2.7
mmol/l
4.2
3.5
—
7
19
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
120
1013
1.61
2.15
4.2
3.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
69
2.29
2.11
2.4
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
97
2.08
2.10
1.1
1.2
iu/ml
17.2
103.7
—
6
42
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
6
15
4.10
2.05
2.2
6.2
%
0.7
0.5
—
6
15
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
149
1340
1.84
1.99
4.5
3.4
mmol/l
2.8
3.0
2.20
136
1265
(3011288) Drugs identified in Urine by Screen method
7
21
3.43
1.98
2.4
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
7
21
3.43
1.98
3.7
4.8
g/l
120.7
134.2
—
7
21
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
143
1273
1.73
1.95
3.9
2.9
mmol/l
1.2
1.2
0.03
130
1203
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
11
4.65
1.95
1.2
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
11
4.65
1.95
1.0
1.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
6
16
3.84
1.95
1.7
3.6
g/l
0.0
0.0
—
6
16
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
16
3.84
1.95
2.2
5.9
%
1.1
1.0
—
6
16
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
6
16
3.84
1.95
1.7
3.9
g/l
0.0
2.7
—
6
16
(21494755) Public health laboratory ask at order entry panel
11
229
0.44
1.88
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
67
2.19
1.81
1.3
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
41
2.53
1.79
1.3
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
24
3.00
1.74
1.6
1.3
—
—
—
0
0
(3020891) Body temperature
5
13
3.93
1.72
1.6
2.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
39
266
1.60
1.72
1.9
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
130
0.37
1.71
1.2
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
8
31
2.66
1.68
3.9
5.8
kpa
4.7
4.8
—
8
31
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
161
1.72
1.64
1.1
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
32
2.57
1.62
1.1
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
37
253
1.59
1.61
4.4
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
41
288
1.56
1.59
1.6
1.5
mmol/l
1.3
1.3
0.24
30
258
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
8
33
2.49
1.56
2.0
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
15
3.40
1.53
1.6
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
58
2.15
1.53
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
9
39
2.38
1.45
3.6
5.4
mmol/l
1.3
1.4
—
9
34
(3021447) Carbon dioxide [Partial pressure] in Venous blood
9
40
2.32
1.42
3.6
5.3
kpa
5.9
6.0
—
9
40
(3012544) pH of Venous blood
9
41
2.26
1.39
3.6
5.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
17
3.00
1.37
1.6
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
36
2.28
1.26
3.6
2.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
12
64
1.94
1.21
20.5
9.9
—
1.0
—
0
11
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
34
244
1.49
1.20
4.6
4.3
ug/l
1.4
2.0
1.21
28
221
(3003327) Ova and parasites identified in Stool by Light microscopy
8
39
2.10
1.17
2.1
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
20
2.54
1.16
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
30
2.39
1.13
1.7
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
30
2.39
1.13
2.7
2.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
41
2.00
1.10
1.1
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
21
2.42
1.10
1.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
67
1.85
1.07
1.5
1.1
—
—
—
0
0
(4010399)
12
69
1.79
0.99
1.7
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
119
0.49
0.98
2.3
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
37
1.93
0.95
1.9
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
18
119
1.57
0.92
1.9
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
18
121
1.54
0.87
1.9
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
31
1.97
0.85
1.3
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
46
1.77
0.84
1.5
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
38
299
1.35
0.82
1.6
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
33
1.85
0.80
1.0
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
15
99
1.56
0.78
1.2
2.5
umol/l
5.7
6.0
—
9
88
(3000991) Gas panel - Venous blood
7
40
1.78
0.72
5.3
7.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
42
1.69
0.69
1.9
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
43
1.65
0.67
1.9
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
43
1.65
0.67
1.9
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
28
1.81
0.66
4.0
8.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
44
1.62
0.66
1.9
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
28
220
1.33
0.62
4.5
2.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
30
1.69
0.62
1.2
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
36
1.69
0.57
1.2
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
192
0.71
0.56
1.8
1.5
—
—
—
0
0
(1002224) Polysomnography panel
9
62
1.48
0.54
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
63
1.45
0.53
1.6
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
48
1.48
0.47
1.3
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
176
1.29
0.44
2.2
1.8
—
—
—
0
0
(4034850)
5
32
1.58
0.42
14.4
3.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
59
1.37
0.41
2.0
1.7
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
27.5
—
0
9
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
34
1.48
0.40
3.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
61
552
1.16
0.38
5.6
3.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
27
233
1.19
0.30
5.7
7.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
129
0.76
0.29
1.2
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
76
1.34
0.29
1.1
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
63
1.28
0.28
1.5
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
113
1.26
0.27
7.5
3.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
39
1.29
0.23
8.8
1.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
42
1.20
0.21
1.0
1.5
pmol/l
384.2
131.0
—
5
42
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.1
—
419.3
—
0
10
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
48
1.26
0.20
1.0
2.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
21
184
1.16
0.20
2.0
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
23
204
1.15
0.19
2.3
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
121
0.82
0.18
1.3
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
78
0.76
0.16
1.7
1.5
—
—
—
0
0
(3019225) pH of Specimen
9
82
1.10
0.15
4.0
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
22
206
1.08
0.07
3.8
3.9
%
17.1
20.4
0.58
12
90
(3003694) ABO and Rh group [Type] in Blood
38
394
0.95
0.05
1.8
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
23
241
0.95
0.04
2.1
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
15
159
0.94
0.03
3.0
2.6
ug/l
0.4
0.6
—
8
100
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
228
0.96
0.02
1.7
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
132
1312
1.03
0.02
11.0
8.0
%
41.4
40.4
1.58
78
1072
(3044640) Blood type and Crossmatch panel - Blood
32
322
0.99
0.00
3.3
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
13
125
1.04
0.00
3.7
3.6
%
34.3
34.3
—
8
84
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
96
0.93
0.00
1.3
1.4
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
76.3
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
88
0.90
0.00
1.3
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
0
5
0.00
0.00
0.0
8.0
—
0.2
—
0
5
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
6
0.00
0.00
0.0
7.0
—
722.8
—
0
6
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
1.1
—
0
9
(3022621) pH of Urine by Test strip
6
64
0.94
0.00
3.5
2.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.4
—
5.1
—
0
7
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint TRACHEOBRONCHOMAL and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have TRACHEOBRONCHOMAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: TRACHEOBRONCHOMAL – Tracheo-bronchomalasia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data